Delphia (USA)’s Octave Specialty Group OSG Stock Holding History

Delphia (USA)’s Portfolio OSG Stock Details OSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,575	Closed	-$234K	–	328
2021 Q4	$234K	Buy	+14,575	New	+$229K	0.25%	176

Other funds holding OSG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CQS (US) New York $367M AUM 8.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Delphia (USA)'s OSG Position: Q1 2022 in Review

Delphia (USA) sold out of Octave Specialty Group (OSG) in Q1 2022, closing a stake of 14,575 shares — an estimated $234K sold.

Delphia (USA) first reported a position in OSG in Q4 2021 and held it in 1 quarter. The position peaked at $234K in Q4 2021. 150 funds tracked by Wall St. Rank hold OSG as of Q1 2022.

Delphia (USA) reported no remaining Octave Specialty Group position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 14,575 Octave Specialty Group shares in Q1 2022, an estimated $234K.
Delphia (USA) first reported a position in Octave Specialty Group in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s Octave Specialty Group position peaked at $234K in Q4 2021.
150 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.